Ladenburg Thalmann Financial Services’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio ITCI Stock Details ITCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$5K	Hold	150	–	–	﹤0.01%	4806
2019 Q3	$1K	Hold	150	–	–	﹤0.01%	5175
2019 Q2	$2K	Hold	150	–	–	﹤0.01%	5017
2019 Q1	$2K	Hold	150	–	–	﹤0.01%	4980
2018 Q4	$2K	Hold	150	–	–	﹤0.01%	4942
2018 Q3	$3K	Hold	150	–	–	﹤0.01%	4805
2018 Q2	$3K	Hold	150	–	–	﹤0.01%	4794
2018 Q1	$3K	Hold	150	–	–	﹤0.01%	4794
2017 Q4	$2K	Hold	150	–	–	﹤0.01%	4813
2017 Q3	$2K	Hold	150	–	–	﹤0.01%	4705
2017 Q2	$2K	Hold	150	–	–	﹤0.01%	4629
2017 Q1	$2K	Hold	150	–	–	﹤0.01%	4604
2016 Q4	$2K	Hold	150	–	–	﹤0.01%	4561
2016 Q3	$2K	Hold	150	–	–	﹤0.01%	4521
2016 Q2	$6K	Hold	150	–	–	﹤0.01%	4065
2016 Q1	$4K	Hold	150	–	–	﹤0.01%	4182
2015 Q4	$8K	Hold	150	–	–	﹤0.01%	3824
2015 Q3	$6K	Buy	+150	New	+$4.89K	﹤0.01%	3862

Other funds holding ITCI

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ladenburg Thalmann Financial Services's ITCI Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services held its Intra-Cellular Therapies Inc. (ITCI) position steady in Q4 2019 at 150 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #4806.

Ladenburg Thalmann Financial Services first reported a position in ITCI in Q3 2015 and has held it in 18 quarters since. The position peaked at $8K in Q4 2015. 133 funds tracked by Wall St. Rank hold ITCI as of Q4 2019.

Ladenburg Thalmann Financial Services held 150 shares of Intra-Cellular Therapies Inc. worth $5K as of Q4 2019.
Ladenburg Thalmann Financial Services left its Intra-Cellular Therapies Inc. share count unchanged in Q4 2019.
Intra-Cellular Therapies Inc. made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #4806 holding.
Ladenburg Thalmann Financial Services first reported a position in Intra-Cellular Therapies Inc. in Q3 2015 and has held it in 18 quarters since.
Ladenburg Thalmann Financial Services's Intra-Cellular Therapies Inc. position peaked at $8K in Q4 2015.
133 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.